{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:19:11Z","timestamp":1786994351941,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000297","name":"Royal College of Surgeons of England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104931\/Z\/14\/Z"],"award-info":[{"award-number":["104931\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014669","name":"British Society for Neuroendocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC-A654-5QB10"],"award-info":[{"award-number":["MC-A654-5QB10"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R010676\/1"],"award-info":[{"award-number":["MR\/R010676\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/L015129\/1"],"award-info":[{"award-number":["BB\/L015129\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","award":["JP20am0101095"],"award-info":[{"award-number":["JP20am0101095"]}],"id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.molmet.2021.101296","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T12:44:50Z","timestamp":1626180290000},"page":"101296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling"],"prefix":"10.1016","volume":"53","author":[{"given":"Emma Rose","family":"McGlone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusman","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Pickford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1542-2348","authenticated-orcid":false,"given":"Stephen R.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2290-8453","authenticated-orcid":false,"given":"Alejandra","family":"Tomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1124\/pr.55.1.6","article-title":"International Union of Pharmacology. XXXV. The glucagon receptor family","volume":"55","author":"Mayo","year":"2003","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S0954422414000031","article-title":"Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes","volume":"27","author":"Marroqui","year":"2014","journal-title":"Nutrition Research Reviews"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2337\/diab.15.10.740","article-title":"Effect of glucagon on the metabolism of lipids and on urea formation by the perfused rat liver","volume":"15","author":"Penhos","year":"1966","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2021.101296_bib5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3168\/jds.S0022-0302(06)72221-4","article-title":"Prevention of fatty liver in transition dairy cows by subcutaneous injections of glucagon","volume":"89","author":"Nafikov","year":"2006","journal-title":"Journal of Dairy Science"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/met.2018.0066","article-title":"Determinants of fasting hyperglucagonemia in patients with type 2 diabetes and nondiabetic control subjects","volume":"16","author":"Demant","year":"2018","journal-title":"Metabolic Syndrome and Related Disorders"},{"issue":"4","key":"10.1016\/j.molmet.2021.101296_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00125-006-0566-z","article-title":"Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus","volume":"50","author":"Knop","year":"2007","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.molmet.2021.101296_bib8","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.bmcl.2015.07.092","article-title":"Recent progress in the development of small-molecule glucagon receptor antagonists","volume":"25","author":"Sammons","year":"2015","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib9","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s00125-017-4354-8","article-title":"GLP-1\/glucagon receptor co-agonism for treatment of obesity","volume":"60","author":"S\u00e1nchez-Garrido","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.molmet.2021.101296_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/db17-0639","article-title":"A\u00a0targeted RNAi screen identifies endocytic trafficking factors that control GLP-1 receptor signaling in pancreatic \u03b2-cells","volume":"67","author":"Buenaventura","year":"2018","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2021.101296_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/acsptsci.0c00022","article-title":"The influence of peptide context on signaling and trafficking of glucagon-like peptide-1 receptor biased agonists","volume":"3","author":"Fang","year":"2020","journal-title":"ACS Pharmacology Translational Science"},{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib12","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41467-018-03941-2","article-title":"Targeting GLP-1 receptor trafficking to improve agonist efficacy","volume":"9","author":"Jones","year":"2018","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/j.molmet.2021.101296_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1074\/jbc.M114.592436","article-title":"Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking","volume":"290","author":"Roed","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.molmet.2021.101296_bib14","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1016\/j.celrep.2016.11.050","article-title":"Downregulation of a GPCR by \u03b2-arrestin2-mediated switch from an endosomal to a TGN recycling pathway","volume":"17","author":"Abdullah","year":"2016","journal-title":"Cell Reports"},{"issue":"45","key":"10.1016\/j.molmet.2021.101296_bib15","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1073\/pnas.1713074114","article-title":"GPCRs globally coevolved with receptor activity-modifying proteins, RAMPs","volume":"114","author":"Barbash","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"9","key":"10.1016\/j.molmet.2021.101296_bib16","doi-asserted-by":"crossref","first-page":"eaaw2778","DOI":"10.1126\/sciadv.aaw2778","article-title":"Multiplexed analysis of the secretin-like GPCR-RAMP interactome","volume":"5","author":"Lorenzen","year":"2019","journal-title":"Science Advances"},{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10409238.2015.1128875","article-title":"The expanding repertoire of receptor activity modifying protein (RAMP) function","volume":"51","author":"Klein","year":"2016","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3565(24)39040-8","article-title":"Amylin receptor phenotypes derived from human calcitonin receptor\/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment","volume":"294","author":"Tilakaratne","year":"2000","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.molmet.2021.101296_bib19","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1074\/jbc.C200629200","article-title":"Novel receptor partners and function of receptor activity-modifying proteins","volume":"278","author":"Christopoulos","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/j.molmet.2021.101296_bib20","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/en.2016-1755","article-title":"RAMP2 influences glucagon receptor pharmacology via trafficking and signaling","volume":"158","author":"Cegla","year":"2017","journal-title":"Endocrinology"},{"issue":"38","key":"10.1016\/j.molmet.2021.101296_bib21","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1074\/jbc.M114.624601","article-title":"Modulation of glucagon receptor pharmacology by receptor activity-modifying protein-2 (RAMP2)","volume":"290","author":"Weston","year":"2015","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/j.molmet.2021.101296_bib22","first-page":"501","article-title":"Potent prearranged positive allosteric modulators of the glucagon-like peptide-1 receptor","volume":"6","author":"Jones","year":"2017","journal-title":"Chemistry Open"},{"issue":"5","key":"10.1016\/j.molmet.2021.101296_bib23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/endo.136.5.7720662","article-title":"An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat","volume":"136","author":"Owji","year":"1995","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/BJ20101721","article-title":"LKB1 is required for hepatic bile acid transport and canalicular membrane integrity in mice","volume":"434","author":"Woods","year":"2011","journal-title":"Biochemical Journal"},{"issue":"3","key":"10.1016\/j.molmet.2021.101296_bib25","doi-asserted-by":"crossref","first-page":"jcs211847","DOI":"10.1242\/jcs.211847","article-title":"Image co-localization - co-occurrence versus correlation","volume":"131","author":"Aaron","year":"2018","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.molmet.2021.101296_bib26","doi-asserted-by":"crossref","first-page":"100133","DOI":"10.1074\/jbc.RA120.016334","article-title":"Genetic and biased agonist-mediated reductions in beta-arrestin recruitment prolong cAMP signalling at glucagon family receptors","volume":"296","author":"Jones","year":"2021","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/j.molmet.2021.101296_bib27","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI92913","article-title":"Hepatic beta-arrestin 2 is essential for maintaining euglycemia","volume":"127","author":"Zhu","year":"2017","journal-title":"Journal of Clinical Investigation"},{"issue":"16","key":"10.1016\/j.molmet.2021.101296_bib28","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1091\/mbc.e12-02-0101","article-title":"Trafficking defects in WASH-knockout fibroblasts originate from collapsed endosomal and lysosomal networks","volume":"23","author":"Gomez","year":"2012","journal-title":"Molecular Biology of the Cell"},{"issue":"17","key":"10.1016\/j.molmet.2021.101296_bib29","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1091\/mbc.e13-02-0092","article-title":"WASH is required for lysosomal recycling and efficient autophagic and phagocytic digestion","volume":"24","author":"King","year":"2013","journal-title":"Molecular Biology of the Cell"},{"issue":"40","key":"10.1016\/j.molmet.2021.101296_bib30","first-page":"E5906","article-title":"WASH drives early recycling from macropinosomes and phagosomes to maintain surface phagocytic receptors","volume":"113","author":"Buckley","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2021.101296_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellsig.2017.04.015","article-title":"Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks","volume":"36","author":"Bahouth","year":"2017","journal-title":"Cellular Signalling"},{"issue":"23","key":"10.1016\/j.molmet.2021.101296_bib32","doi-asserted-by":"crossref","first-page":"14762","DOI":"10.1016\/S0021-9258(17)42668-8","article-title":"Complete inhibition of transferrin recycling by monensin in K562 cells","volume":"259","author":"Stein","year":"1984","journal-title":"Journal of Biological Chemistry"},{"issue":"25","key":"10.1016\/j.molmet.2021.101296_bib33","doi-asserted-by":"crossref","first-page":"23926","DOI":"10.1074\/jbc.M501751200","article-title":"Receptor activity-modifying protein (RAMP) isoform-specific regulation of adrenomedullin receptor trafficking by NHERF-1","volume":"280","author":"Bomberger","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"48","key":"10.1016\/j.molmet.2021.101296_bib34","doi-asserted-by":"crossref","first-page":"24093","DOI":"10.1073\/pnas.1905561116","article-title":"RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis","volume":"116","author":"Mackie","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"19","key":"10.1016\/j.molmet.2021.101296_bib35","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.RA118.001975","article-title":"Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells","volume":"293","author":"Wan","year":"2018","journal-title":"Journal of Biological Chemistry"},{"issue":"7442","key":"10.1016\/j.molmet.2021.101296_bib36","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature12000","article-title":"Conformational biosensors reveal GPCR signalling from endosomes","volume":"495","author":"Irannejad","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2021.101296_bib37","first-page":"000270","article-title":"Acylation of the incretin peptide exendin-4 directly impacts GLP-1 receptor signalling and trafficking","volume":"100","author":"Lucey","year":"2021","journal-title":"Molecular Pharmacology"},{"issue":"11","key":"10.1016\/j.molmet.2021.101296_bib38","first-page":"679","article-title":"To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nature reviews","volume":"19","author":"Cullen","year":"2018","journal-title":"Molecular Cell Biology"},{"issue":"49","key":"10.1016\/j.molmet.2021.101296_bib39","doi-asserted-by":"crossref","first-page":"16630","DOI":"10.1074\/jbc.RA120.014532","article-title":"Agonist-activated glucagon receptors are deubiquitinated at early endosomes by two distinct deubiquitinases to facilitate Rab4a-dependent recycling","volume":"295","author":"Kaur","year":"2020","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib40","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nchembio.206","article-title":"Sustained cyclic AMP production by parathyroid hormone receptor endocytosis","volume":"5","author":"Ferrandon","year":"2009","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.molmet.2021.101296_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coemr.2020.07.003","article-title":"Spatiotemporal control of GLP-1 receptor activity","volume":"16","author":"Manchanda","year":"2021","journal-title":"Current Opinion in Endocrine and Metabolic Research"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib42","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.molmet.2017.08.002","article-title":"G\u03b1s regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment","volume":"6","author":"Girada","year":"2017","journal-title":"Molecular Metabolism"},{"issue":"2","key":"10.1016\/j.molmet.2021.101296_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/acsptsci.0c00006","article-title":"Emerging role of compartmentalized G protein-coupled receptor signaling in the cardiovascular field","volume":"3","author":"Plouffe","year":"2020","journal-title":"ACS Pharmacology Translational Science"},{"issue":"3","key":"10.1016\/j.molmet.2021.101296_bib44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tem.2016.10.007","article-title":"GPCR signaling and trafficking: the long and short of it","volume":"28","author":"Pavlos","year":"2017","journal-title":"Trends in Endocrinology and Metabolism: Trends in Endocrinology and Metabolism"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib45","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.tips.2018.08.003","article-title":"Therapeutic targeting of endosomal G-protein-coupled receptors","volume":"39","author":"Thomsen","year":"2018","journal-title":"Trends in Pharmacological Sciences"},{"issue":"10","key":"10.1016\/j.molmet.2021.101296_bib46","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1073\/pnas.1701529114","article-title":"Distinct conformations of GPCR-beta-arrestin complexes mediate desensitization, signaling, and endocytosis","volume":"114","author":"Cahill","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.molmet.2021.101296_bib47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2017.01.052","article-title":"beta-arrestin signalling and bias in hormone-responsive GPCRs","volume":"449","author":"Reiter","year":"2017","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"5","key":"10.1016\/j.molmet.2021.101296_bib48","doi-asserted-by":"crossref","first-page":"C1230","DOI":"10.1152\/ajpcell.00240.2008","article-title":"Glucagon receptor recycling: role of carboxyl terminus, beta-arrestins, and cytoskeleton","volume":"295","author":"Krilov","year":"2008","journal-title":"American Journal of Physiology - Cell Physiology"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2021.101296_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2006.04.006","article-title":"The gene expression of adrenomedullin, calcitonin-receptor-like receptor and receptor activity modifying proteins (RAMPs) in CCl4-induced rat liver cirrhosis","volume":"135","author":"Hwang","year":"2006","journal-title":"Regulatory Peptides"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:28:23Z","timestamp":1761956903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":48,"alternative-id":["S2212877821001411"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101296","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.09.443291","asserted-by":"object"}]},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101296"}}